Consensus Becton, Dickinson and Company

Stocks

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 04:00:02 19/09/2026 HKT			5-day change	1st Jan Change
180.94 ^USD	-0.24%		+1.74%	-6.77%

09-18	Jana urges Cooper to replace CEO, explore asset sales after performance setbacks	RE
09-14	Becton, Dickinson And Company Deploys BD Vmax 160 Pharmacy Automation Robot At Fairview Health Services	CI

Evolution of the Average Target: Becton, Dickinson and Company

Evolution of the Target Price: Becton, Dickinson and Company

Changes in Analyst Recommendations: Becton, Dickinson and Company

d91f94c05dc098821538303d48e51c9d._2FS6PkT1TtKssjMWjnjumvJrFIrm5ow6OS46smsRfc.ticlmaBFhWo74KyfIHqAjAeNmiZD7_Z-gK_T3q7mH8e2V2CGjFDgaTPbrw~d46dfcde00a9d10300f5b8ee634f9b92

Analysts' recommendations: Becton, Dickinson and Company

08-31	BofA Adjusts Price Target on Becton Dickinson and Co. to $200 From $185	MT
08-14	Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says	MT
08-13	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $208 From $204, Maintains Buy Rating	MT
08-13	RBC Adjusts PT on Becton Dickinson and Co. to $190 From $180, Keeps Sector Perform Rating	MT
08-12	UBS Adjusts Becton Dickinson and Co. PT to $205 From $190, Maintains Buy Rating	MT
08-08	Wells Fargo Adjusts Price Target on Becton Dickinson and Co. to $170 From $161	MT
08-08	Jefferies Adjusts Price Target on Becton Dickinson and Co. to $210 From $190	MT
08-08	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $204 From $198	MT
08-08	Piper Sandler Adjusts Price Target on Becton Dickinson and Co. to $175 From $161	MT
08-08	JPMorgan Adjusts Price Target on Becton Dickinson and Co. to $188 From $175	MT
08-07	RBC Adjusts PT on Becton Dickinson and Co. to $180 From $175, Maintains Sector Perform Rating	MT
08-06	TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $182 From $163	MT
07-28	UBS Initiates Coverage on Becton, Dickinson and Company With Buy Rating, $190 Price Target	MT
07-14	Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating	MT
07-09	Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says	MT
07-06	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $180 From $190	MT
06-12	BofA Adjusts Price Target on Becton, Dickinson and Company to $170 From $177	MT
05-27	Goldman Sachs Adjusts PT on Becton, Dickinson and Co. to $150 From $156, Maintains Neutral Rating	MT
05-09	Becton, Dickinson Building Growth After 'Clean' Fiscal Q2 Beat, RBC Says	MT
05-08	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $190 From $180	MT
05-07	Stifel Nicolaus Adjusts Becton, Dickinson and Company Price Target to $175 From $215	MT
05-04	TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $163 From $189, Maintains Hold Rating	MT
05-04	U.S. research roundup - Alphabet, Colgate-Palmolive, Welltower	RE
04-17	Piper Sandler Adjusts Becton, Dickinson and Company PT to $159 From $170, Maintains Neutral Rating	MT
04-14	RBC Cuts Price Target on Becton, Dickinson to $175 From $195, Keeps Sector Perform Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	BECTON, DICKINSON AND COMPANY					+8.14%
	ABBOTT LABORATORIES					+17.2%
	MEDTRONIC PLC					+13.79%
	CENCORA, INC.					+19.6%
	HOYA CORPORATION					+33.6%
	DEXCOM, INC.					+5.74%
	MEDLINE INC.					+40.96%
	WEST PHARMACEUTICAL SERVICES, INC.					+11.89%
	SARTORIUS STEDIM BIOTECH					+18.88%
	TERUMO CORPORATION					+38.96%
	Average					+20.88%
	Weighted average by Cap.					+18.43%